The study reveals SGLT-2is are linked to fewer COPD exacerbations in type 2 diabetes, suggesting a need for further clinical ...

Lilly will provide an initial payment to complete a Phase I trial of OLX75016, which started in February 2024.

In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...

Controversy surrounded Hims & Hers’ commercial, called ‘Sick of the System’, in the lead up to America’s biggest sporting ...

Allurion’s CEO confirmed to Medical Device Network that the company has changed advertising, patient follow-up, and physician ...

Aardvark’s lead candidate ARD-101 is being investigated in a Phase III study for hyperphagia in Prader-Willi syndrome.

Compared to usual care, GLP-1RA use was linked to a reduced risk of various neurocognitive disorders, substance use and psychotic disorders, seizures, coagulation disorders, cardiometabolic ...

Research reveals semaglutide's effectiveness in decreasing alcohol consumption and cravings, highlighting its potential for treating alcohol use disorder.

Earlier this month, the FDA put out a statement saying that it, too, was concerned about patients and healthcare professionals turning to unapproved versions of GLP-1 drugs as an option for weight ...

Kendrick Lamar and Drake spent last spring trading disses. The rappers unleashed a slew of increasingly brutal attack tracks, taking aim at each other’s talent, parenting and race, among other ...